Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Booker v. C R Bard Incorporated et al
-
April 24, 2018
Bard Seeks New Trial Over Vein Filters After $3.6M Verdict
Medical device maker C.R. Bard on Monday moved for a new trial after being hit with a $3.6 million verdict last month in a multidistrict litigation test trial over the safety of its clot-stopping vein filters, telling an Arizona federal court the decision was "inconsistent" and rested on flimsy evidence.
-
March 30, 2018
Bard Owes Injured Woman $3.6M In IVC Bellwether, Jury Finds
A Phoenix federal jury awarded $2 million in compensatory damages and $2 million in punitive damages on Friday to a woman who said a clot-stopping vein filter manufactured by C.R. Bard Inc. broke apart in her body, finding the device maker responsible for 80 percent of the harm for a total of $3.6 million in damages.
-
March 29, 2018
First Bard Vein Filter Bellwether Heads To Jury
A Phoenix federal jury began deliberations Thursday in the first bellwether trial in multidistrict litigation over claims that device maker Bard's clot-stopping vein implants splintered and migrated towards patients' hearts, after Bard closed its case by arguing evidence concerning predecessor implants and FDA warnings were red herrings.